Cost-effectiveness analysis of treatment strategies initiating with second-generation antipsychotic long-acting injectables in patients with schizophrenia in the United States.

Zyprexa Relprevv (olanzapine pamoate long-acting injection) - Cheplapharm

olanzapine - Generic mfg.

risperidone - Generic mfg.

Invega Sustenna (paliperidone palmitate extended-release 1-month injection) - J&J

clozapine - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42043922

Cindy M Chan; K N Roy Chengappa; Kangho Suh; Tushita Mayanil

Apr 27, 2026